Dobutamine Cardiovascular Magnetic Resonance for the Detection of Myocardial Ischemia With the Use of Myocardial Tagging

Background—The purpose of this study was to assess the value of high-dose dobutamine cardiovascular magnetic resonance (CMR) with myocardial tagging for the detection of wall motion abnormalities as a measure of myocardial ischemia in patients with known or suspected coronary artery disease. Methods and Results—Two hundred eleven consecutive patients with chest pain underwent dobutamine-CMR 4 days after antianginal medication was stopped. Dobutamine-CMR was performed at rest and during increasing doses of dobutamine. Cine-images were acquired during breath-hold with and without myocardial tagging at 3 short-axis levels. Regional wall motion was assessed in a 16-segment short-axis model. Patients with new wall motion abnormalities (NWMA) were examined by coronary angiography. Dobutamine-CMR was successfully performed in 194 patients. Dobutamine-CMR without tagging detected NWMA in 58 patients, whereas NWMA were detected in 68 patients with tagging (P =0.002, McNemar). Coronary angiography showed coronary artery disease in 65 (96%) of these 68 patients. All but 3 of the 65 patients needed revascularization. In the 112 patients with a negative dobutamine-CMR study, without baseline wall motion abnormalities, the cardiovascular occurrence-free survival rate was 98.2% during the mean follow-up period of 17.3 months (range, 7 to 31). Conclusions—Dobutamine-CMR with myocardial tagging detected more NWMA compared with dobutamine-CMR without tagging and reliably separated patients with a normal life expectancy from those at increased risk of major adverse cardiac events.

[1]  J. Willerson,et al.  Effects of inotropic and chronotropic stimuli on acute myocardial ischemic injury. I. Studies with dobutamine in the anesthetized dog. , 1982, Circulation.

[2]  R G Gould,et al.  Measurement of right and left ventricular volumes in healthy individuals with cine MR imaging. , 1987, Radiology.

[3]  E. Zerhouni,et al.  Human heart: tagging with MR imaging--a method for noninvasive assessment of myocardial motion. , 1988, Radiology.

[4]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[5]  L. Axel,et al.  Heart wall motion: improved method of spatial modulation of magnetization for MR imaging. , 1989, Radiology.

[6]  L D Hall,et al.  Cardiac tagging in the rat using a DANTE sequence , 1991, Magnetic resonance in medicine.

[7]  Sensitivities of cardiac O2 consumption and contractility to catecholamines in dogs. , 1991, The American journal of physiology.

[8]  A. Salustri,et al.  Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. , 1992, The American journal of cardiology.

[9]  E. Picano,et al.  Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Echo Dobutamine International Cooperative Study Group. , 1994, Lancet.

[10]  E. Picano,et al.  Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study , 1994, The Lancet.

[11]  H Azhari,et al.  A noninvasive comparative study of myocardial strains in ischemic canine hearts using tagged MRI in 3-D. , 1995, The American journal of physiology.

[12]  R. Mccoll,et al.  Noninvasive quantitation of left ventricular wall thickening using cine magnetic resonance imaging with myocardial tagging. , 1995, The American journal of cardiology.

[13]  J. Roelandt,et al.  Relation between contractile response of akinetic segments during dobutamine stress echocardiography and myocardial ischemia assessed by simultaneous thallium-201 single-photon emission computed tomography. , 1996, The American journal of cardiology.

[14]  C. Kramer,et al.  Quantitative assessment of myocardial viability after infarction by dobutamine magnetic resonance tagging. , 1998, Circulation.

[15]  R M Peshock,et al.  Dobutamine magnetic resonance imaging with myocardial tagging quantitatively predicts improvement in regional function after revascularization. , 1998, The American journal of cardiology.

[16]  Jeroen J. Bax,et al.  The functional significance of chronotropic incompetence during dobutamine stress test , 1999, Heart.

[17]  E. Fleck,et al.  Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. , 1999, Circulation.

[18]  W. Hundley,et al.  Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. , 1999, Circulation.

[19]  Jeroen J. Bax,et al.  Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease: A single-center experience. , 1999, Circulation.

[20]  Jerry L Prince,et al.  Fast determination of regional myocardial strain fields from tagged cardiac images using harmonic phase MRI. , 2000, Circulation.

[21]  E. Fleck,et al.  Real-time MR image acquisition during high-dose dobutamine hydrochloride stress for detecting left ventricular wall-motion abnormalities in patients with coronary arterial disease. , 2002, Radiology.